205 related articles for article (PubMed ID: 18695000)
1. PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.
Wee HJ; Voon DC; Bae SC; Ito Y
Blood; 2008 Nov; 112(9):3777-87. PubMed ID: 18695000
[TBL] [Abstract][Full Text] [Related]
2. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
[TBL] [Abstract][Full Text] [Related]
3. Accelerated leukemogenesis by truncated CBF beta-SMMHC defective in high-affinity binding with RUNX1.
Kamikubo Y; Zhao L; Wunderlich M; Corpora T; Hyde RK; Paul TA; Kundu M; Garrett L; Compton S; Huang G; Wolff L; Ito Y; Bushweller J; Mulloy JC; Liu PP
Cancer Cell; 2010 May; 17(5):455-68. PubMed ID: 20478528
[TBL] [Abstract][Full Text] [Related]
4. Runx1 is required for hematopoietic defects and leukemogenesis in Cbfb-MYH11 knock-in mice.
Hyde RK; Zhao L; Alemu L; Liu PP
Leukemia; 2015 Aug; 29(8):1771-8. PubMed ID: 25742748
[TBL] [Abstract][Full Text] [Related]
5. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
6. PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.
Shima Y; Shima T; Chiba T; Irimura T; Pandolfi PP; Kitabayashi I
Mol Cell Biol; 2008 Dec; 28(23):7126-38. PubMed ID: 18809579
[TBL] [Abstract][Full Text] [Related]
7. Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta.
Gorczynski MJ; Grembecka J; Zhou Y; Kong Y; Roudaia L; Douvas MG; Newman M; Bielnicka I; Baber G; Corpora T; Shi J; Sridharan M; Lilien R; Donald BR; Speck NA; Brown ML; Bushweller JH
Chem Biol; 2007 Oct; 14(10):1186-97. PubMed ID: 17961830
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.
Kanno Y; Kanno T; Sakakura C; Bae SC; Ito Y
Mol Cell Biol; 1998 Jul; 18(7):4252-61. PubMed ID: 9632809
[TBL] [Abstract][Full Text] [Related]
9. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.
Huang G; Shigesada K; Ito K; Wee HJ; Yokomizo T; Ito Y
EMBO J; 2001 Feb; 20(4):723-33. PubMed ID: 11179217
[TBL] [Abstract][Full Text] [Related]
10. Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBFβ interaction.
Cunningham L; Finckbeiner S; Hyde RK; Southall N; Marugan J; Yedavalli VR; Dehdashti SJ; Reinhold WC; Alemu L; Zhao L; Yeh JR; Sood R; Pommier Y; Austin CP; Jeang KT; Zheng W; Liu P
Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14592-7. PubMed ID: 22912405
[TBL] [Abstract][Full Text] [Related]
11. The chimeric protein, PEBP2 beta/CBF beta-SMMHC, disorganizes cytoplasmic stress fibers and inhibits transcriptional activation.
Tanaka Y; Fujii M; Hayashi K; Chiba N; Akaishi T; Shineha R; Nishihira T; Satomi S; Ito Y; Watanabe T; Satake M
Oncogene; 1998 Aug; 17(6):699-708. PubMed ID: 9715271
[TBL] [Abstract][Full Text] [Related]
12. Runx1/AML1 in normal and abnormal hematopoiesis.
Yamagata T; Maki K; Mitani K
Int J Hematol; 2005 Jul; 82(1):1-8. PubMed ID: 16105753
[TBL] [Abstract][Full Text] [Related]
13. Autonomous feedback loop of RUNX1-p53-CBFB in acute myeloid leukemia cells.
Morita K; Noura M; Tokushige C; Maeda S; Kiyose H; Kashiwazaki G; Taniguchi J; Bando T; Yoshida K; Ozaki T; Matsuo H; Ogawa S; Liu PP; Nakahata T; Sugiyama H; Adachi S; Kamikubo Y
Sci Rep; 2017 Nov; 7(1):16604. PubMed ID: 29192243
[TBL] [Abstract][Full Text] [Related]
14. Interaction and cooperation of the CCAAT-box enhancer-binding protein β (C/EBPβ) with the homeodomain-interacting protein kinase 2 (Hipk2).
Steinmann S; Coulibaly A; Ohnheiser J; Jakobs A; Klempnauer KH
J Biol Chem; 2013 Aug; 288(31):22257-69. PubMed ID: 23782693
[TBL] [Abstract][Full Text] [Related]
15. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
Miller JD; Stacy T; Liu PP; Speck NA
Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
[TBL] [Abstract][Full Text] [Related]
16. Runx1 binds as a dimeric complex to overlapping Runx1 sites within a palindromic element in the human GM-CSF enhancer.
Bowers SR; Calero-Nieto FJ; Valeaux S; Fernandez-Fuentes N; Cockerill PN
Nucleic Acids Res; 2010 Oct; 38(18):6124-34. PubMed ID: 20483917
[TBL] [Abstract][Full Text] [Related]
17. Regulation mechanisms for the heterodimeric transcription factor, PEBP2/CBF.
Bae SC; Ito Y
Histol Histopathol; 1999 Oct; 14(4):1213-21. PubMed ID: 10506937
[TBL] [Abstract][Full Text] [Related]
18. Chromatin regulation by AML1 complex.
Yoshida H; Kitabayashi I
Int J Hematol; 2008 Jan; 87(1):19-24. PubMed ID: 18224409
[TBL] [Abstract][Full Text] [Related]
19. PEBP2 alpha B/mouse AML1 consists of multiple isoforms that possess differential transactivation potentials.
Bae SC; Ogawa E; Maruyama M; Oka H; Satake M; Shigesada K; Jenkins NA; Gilbert DJ; Copeland NG; Ito Y
Mol Cell Biol; 1994 May; 14(5):3242-52. PubMed ID: 8164679
[TBL] [Abstract][Full Text] [Related]
20. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
